Drug targeting. Breaking down barriers.
Greg
G
Miller
D000818:Animals; D001812:Blood-Brain Barrier; D001921:Brain / Q000098:blood supply / Q000378:metabolism / Q000648:ultrastructure; D001927:Brain Diseases / Q000188:drug therapy* / Q000628:therapy; D002196:Capillaries / Q000648:ultrastructure; D002352:Carrier Proteins / Q000378:metabolism*; D004337:Drug Carriers; D016503:Drug Delivery Systems; D004345:Drug Industry; D004730:Endothelium, Vascular / Q000648:ultrastructure; D015316:Genetic Therapy; D006801:Humans; D036103:Nanotechnology; D009414:Nerve Growth Factors / Q000008:administration & dosage / Q000378:metabolism; D016372:RNA, Antisense / Q000008:administration & dosage; D011972:Receptor, Insulin / Q000378:metabolism; D011990:Receptors, Transferrin / Q000378:metabolism; D019108:Tight Junctions / Q000648:ultrastructure
D002352:Carrier Proteins; D004337:Drug Carriers; D009414:Nerve Growth Factors; D016372:RNA, Antisense; D011990:Receptors, Transferrin; D011972:Receptor, Insulin